EXAGEN INC. Variable Lease, Cost
EXAGEN INC. (XGN) reported Variable Lease, Cost of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-10
- EXAGEN INC. variable lease, cost for the quarter ending 2022-12-31 was $41.00K.
- EXAGEN INC. variable lease, cost for the quarter ending 2022-09-30 was $41.00K.
- EXAGEN INC. variable lease, cost for the quarter ending 2022-06-30 was $42.00K.
- EXAGEN INC. variable lease, cost for the quarter ending 2022-03-31 was $42.00K.
- EXAGEN INC. variable lease, cost for fiscal 2025 was $200.00K, a 0.00% change from fiscal 2024.
- EXAGEN INC. variable lease, cost for fiscal 2024 was $200.00K, a 55.04% increase from fiscal 2023.
- EXAGEN INC. variable lease, cost for fiscal 2023 was $129.00K, a 21.82% decline from fiscal 2022.
- EXAGEN INC. variable lease, cost for fiscal 2022 was $165.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-03-10 | ||||
| 2024-12-31 | $200.00K 10-K · filed 2026-03-10 | $196.00K 10-K · filed 2025-03-11 | |||
| 2023-12-31 | $129.00K 10-K · filed 2025-03-11 | ||||
| 2022-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $82.00K derived: sum of 2 quarters · filed 2024-03-18 | $124.00K derived: sum of 3 quarters · filed 2024-03-18 | $165.00K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $41.00K 10-Q · filed 2022-11-21 | $83.00K derived: sum of 2 quarters · filed 2022-11-21 | $124.00K 10-Q · filed 2022-11-21 | ||
| 2022-06-30 | $42.00K 10-Q/A · filed 2022-11-21 | $84.00K 10-Q/A · filed 2022-11-21 | |||
| 2022-03-31 | $42.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |